Clinical Research Directory
Browse clinical research sites, groups, and studies.
Brain Function and Psychological Changes Related to Cell Therapy for Autoimmune Hemolytic Anemia
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Summary
Cell therapy is an innovative treatment with significant efficacy in hematologic and certain autoimmune diseases. Although it offers potential benefits for autoimmune hemolytic anemia (AIHA), it may result in cognitive and other potential impairments, which can adversely affect patients' cognition and behavior. Brain function and psychological assessment are essential for the early detection of potential impairments, allowing timely interventions to prevent complications and ensure patient safety. This study aims to comprehensively evaluate the physical and psychological impacts of cell therapy on AIHA patients to develop safer and more effective treatment strategies that enhance their quality of life.
Official title: Brain Function and Psychological Assessment in Patients With Autoimmune Hemolytic Anemia Undergoing Cell Therapy
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2025-02-25
Completion Date
2026-12-31
Last Updated
2025-08-05
Healthy Volunteers
No
Interventions
Brain function and psychological assessment
Patients will be assessed before cell therapy and on Days 1, 4, 7, 10, 14, 21, and 28 after treatment.
Locations (1)
Regenerative Medicine Center
Tianjin, Tianjin Municipality, China